My watch list  

99 Current news of High-Tech Gründerfonds Management


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Advance Gene Therapy Pipeline for Musculoskeletal Diseases

GeneQuine Biotherapeutics Secures more than €9 Million


GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has raised €5.4 million in Series A financing and €3.65 million non-dilutive funding bringing the total amount raised to €9.05 million. The Series A ...


image description
New separation technology for biomolecules

i3 Membrane receives 7 figure sum for development and market launch


Four investors are financing the further growth of i3 Membrane GmbH. High-tech venture capital investor HTGF from Bonn, Germany, and three private investors are together investing a 7 figure sum in the further development and market launch of new separation technology for biological molecules. ...


image description
Transformation of lignin into tailor made particles for life science applications

LignoPure secures € 2.2 Million seed round


LignoPure invented a unique approach to replace plastics through utilization of wood waste and the team just closed its seed round with HTGF, IFH and Tanovis AG to scale its own technology for the transformation of lignin – a byproduct of the pulp and paper industries and biorefineries – into ...


image description
Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis

Start-up announces $24 million Series A financing and appoints Jason T. Gammack as CEO


Resolve Biosciences, the pioneer in Molecular Cartography™, announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as Chief Executive Officer. The company’s Molecular Cartography platform is a groundbreaking multi-analyte and highly ...


image description
Deep learning for faster, more accurate and safer MRI analysis

International pool invests ~ 2 Mio € in medicine start-up mediaire


HTGF, primeCROWD and LIFTT are part of an international round for the development of “Deep learning diagnostic” which allows faster, more accurate and safer MRI analysis. Expansion into European markets will start in 2021 accompanied by a significant expansion of product portfolio mediaire, the ...


image description
Gilead Sciences to Acquire MYR GmbH

One of the largest trade sales of a VC-financed German biotech start-up in the last 20 years - first HTGF unicorn


Gilead Sciences, Inc. and MYR GmbH announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire MYR for approximately €1.15 bn in cash, payable upon closing of the transaction plus a potential future milestone payment of up to €0.3 bn million (both ...


image description
Emergence Therapeutics Announces a Bumped-up Follow-on Seed Round Financing

Financing enables company to embark on additional targets and expand ADC technology reach


Emergence Therapeutics AG, a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, announces that is has closed a Bumped-up Follow-on Seed Round Financing from a syndicate of leading European investors comprising ...


image description
Novel label-free biosensor platform for innovate modern drug screening

lino Biotech closes seed financing round


After almost a decade of initial invention and joint research on the Focal Molography technology at Roche, a leading player in the diagnostics and pharmaceutical area, and ETH Zurich as one of Europe’s most renowned research institutes, lino Biotech AG has licensed the technology to further ...


image description
5 million euros for digital health start-up

For the first time, Patient-Reported Outcome Measures are systematically linked to clinical data to improve treatment and research


The digital health start-up heartbeat medical has closed a Series A financing round with a volume of 5 million euros. The funds will be used to support organisational development and the expansion of capabilities of skills in the field of data analysis. There is a great need for better data in ...


image description
Start-up receives €24 million for the development of a potential COVID-19 treatment

EIB backs Atriva Therapeutics


The European Investment Bank (EIB) and Atriva Therapeutics GmbH, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, concluded a €24 million financing agreement to facilitate the company’s development and clinical testing of a novel therapy treating ...


Page 1 From 10
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE